FDA Announces Recall of "DU" Brand Nasal Decongestant Due to Possible Health Risk


WASHINGTON - The Food and Drug Administration (FDA) has alerted consumers not to purchase or use a recalled lot of DU brand nasal decongestant spray (distributed by Drugs Unlimited, of Puerto Rico) because it may be contaminated with Burkholderia cepacia - a bacterium that could cause serious, potentially life-threatening infections in some patients. Individuals with compromised immune systems, especially those with cystic fibrosis, could be at risk.

The recalled product is sold over the counter in 15 milliliter and 30 milliliter bottles labeled "DU 12-Hour Nasal Spray" with the lot number J4492 imprinted at the bottom of the carton and the back of the bottle label. The recalled product also bears an expiration date of 9/06.

The product appears to have been distributed throughout Puerto Rico and it is likely linked to an earlier recall of other contaminated product lots that were sold to other distributors.

Consumers who have used the recalled product may want to consult their physicians. Consumers who may still have the recalled product should not use it, but instead return it immediately to the stores where it was purchased. Wholesalers and retailers who purchased the product should return it to the appropriate distribution center.

Source: FDA

Related Videos
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Related Content